
|Videos|March 28, 2016
Guidelines Pharmacists Should Refer to When Selecting a Novel Oral Anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
From Stigma to Breakthrough: Psychedelic Medicine
2
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
3
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
4
How Pharmacy and Public Health Partner to Combat Infectious Diseases
5